2018-12-20
Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer"
Publication
Publication
New England Journal of Medicine , Volume 379 - Issue 25 p. 2481
Additional Metadata | |
---|---|
doi.org/10.1056/NEJMc1814750, hdl.handle.net/1765/113488 | |
New England Journal of Medicine | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Coebergh van den Braak, R.R.J, Martens, J.W.M, & IJzermans, J.N.M. (2018). Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer". New England Journal of Medicine, 379(25). doi:10.1056/NEJMc1814750
|